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a  b  s  t  r  a  c  t
Around  60%  of  new  cancer  patients  and  23%  of previously  radiotherapy-treated  patients  need radiothe-
rapy  for management  of their  cancer.  Although  radiotherapy  demands  <6%  of budget  of cancer,  huge
initial  out-lay  makes  it apparently  expensive.  Technological  innovation  has  increased  number  of radio-
therapy  planning  and delivery  equipments  at an  unprecedented  rate.  Improved  precision  of technological
innovation  has  decreased  the  clinical  adverse  events  albeit  the  questionable  accuracy  of dose  delivered.
However,  new  radiotherapy  equipments  are  expensive,  sophisticated  and  difﬁcult  to  operate  without  anyinear accelerator
obalt-60
adiotherapy technology
difference in  survival.  Novel  technology  has  decreased  access  to  radiotherapy  in resource-constrained
developing  countries.  Tele-therapy  and  brachytherapy  machine  with  Co-60  radio-isotope  as  the  source
of radiation  may  be feasible  and  inexpensive  option  for countries  like India.  Advanced  techniques  and
linac-based  therapy  may  be restricted  for selective  cases  and  should  always  be  carried-out  within  the
scope of  clinical  trials.
©  2015  Published  by Elsevier  Ltd.  This is an  open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).India is seventh largest country in the world by area and
econd most populous country with 1.24 billion people. Indian
ominal and purchasing power parity (PPP) gross domestic prod-
ct (GDP) is tenth and third largest in the world respectively.
ndia has emerged as one of the fastest-growing economies in the
orld [1]. All of booming Indian economy, signiﬁcant contribu-
ion of the new industries to the robust economy, willingness to
radually become independent of foreign aid, abundant natural
esources, well-established indigenous manufacturing industrial
ector, capability to manufacture nuclear power and weapons, and
orld-envying highly sophisticated and modernized space pro-
ramme  has helped India to make its appearance in various world
eaders’ summit. Due to its increasing global inﬂuence, India is
n race for the permanent membership of World Security Coun-
il. India has been visualized as a future new engine of World
conomy [2–6]. With this background, it would not be inappro-
riate, irrelevant for India to aspire to have and treat patients with
 This article has won third prize in against category of Discussion Forum Con-
est 2013 of Association of Medical Physicists of India. Topic of the contest was
Fast-paced technological advancement in radiation treatment equipment is good
or Indian Scenario”.
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213-5383/© 2015 Published by Elsevier Ltd. This is an open access article under the CC Bstate-of-art, advanced, latest, up-to-date armamentarium of radio-
therapy equipments. The ﬁeld of radiation oncology has witnessed
unprecedented technical advances after 1980s that included new
imaging modalities (4-D computed tomography, functional mag-
netic resonance imaging and molecular imaging) to simulate the
patients for more accurate delineation of tumour and critical nor-
mal  tissues, robust radiotherapy planning computers and software
(algorithm) for smart-segmentation, auto-contouring, radiation
beam optimization and dosimetry and precise target localization
(continuous image guidance of cone-beam computed tomography
and ﬂuoroscopy, gating of beam to track the moving targets, phe-
nomenal control of movement of couch and direction by robotics)
and novel implementation systems such as advanced linear accel-
erators [7].
Discovery of X-ray and radium by Wilhelm Codrad Roentgen
and Marie Curie in years 1895 and 1898 respectively marked the
beginning of treatment of cancer with radiation therapy. Radium-
226 (Ra-226) was  the radioisotope used to treat cancer by both
teletherapy and brachytherapy until it was  replaced by Cobalt-60
(Co60) in 1951 due to concern of long half-life of Ra-226. Around the
same time, medical linear accelerators emerged as an alternative
source of mega-voltage radiation. Much advance in the planning
and delivery of radiotherapy is possible with the advent of three
dimensional imaging, differentially moving 5 cm thick lead leaves
of multi-leaf collimator (MLC), application of computers. Coutard’s
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Availability of radiotherapy machine per million population around the globe. Directory of Radiotherapy Centres (DIRAC) 2012 of IAEA shades nation across the world
a  each o
D
P S.Loof
o
i
f
W
t
a
r
o
C
X
t
t
a
o
i
t
I
e
t
A
I
c
pccording to available number of radiotherapy machines per million population in
irectory of Radiotherapy Centres database [3].
ermission for using this map  has been obtained from IAEA through the Email IDs: 
bservation of results of animal experiment of Claudius Regaud
nspired him to develop fractionated radiotherapy. Conventionally
ractionated radiotherapy has been the standard of care since then.
axing and waning interest on the clinical use of altered frac-
ionation, hypofractioned radiotherapy, stereotactic radiotherapy
nd radio-surgery is evident right from the beginning of clinical
adiotherapy to date [8].
India was and is fortunate to be one of the early beneﬁciaries
f western discovery and invention. India commissioned the ﬁrst
o60 teletherapy unit at the Cancer Institute, Chennai in 1956. Deep
-ray therapy and radium brachytherapy were used in almost all
he cancer facilities across India [9]. Cancer hospitals in India are
aking pride of executing the latest of technology in radiotherapy
nd are on their marks to acquire, expertise and propagate any
f the contemporary technology that may  be launched in market
n the near-future [10]. Given the extremely advantageous posi-
ion of India among the countries of the world, magnitude of the
ndian economy, technical skills and expertise, one would naturally
xpect gleaming India in the world map  of availability of radio-
herapy machine per million population released by International
tomic Energy Agency (IAEA).
However, Directory of Radiotherapy Centres (DIRAC) 2012 of
AEA has grouped India (Fig. 1) with poorest Sub-Saharan African
ountries with less than one radiotherapy machine per million peo-
le [11]. Apathetic state of Indian radiotherapy cannot be explainedf the countries. This map was produced in 2012, using information from the IAEA
@iaea.org & Info@iaea.org on 28th August 2014.
by gigantic population, difﬁcult geography, magnitude of land sur-
face area or the booming economy. Aforementioned reasons do not
ﬁnd validity and basis if we compare ourselves with our immediate
neighbour Peoples’ Republic of China, another emerging economy
with similar socio-economic, demographic, geographic and cultural
proﬁle [6]. Current Indian radiotherapy scenario is gloomy reﬂec-
tion of the sad state-of-affairs of both Indian health systems as well
as the stagnant human development indices (HDI) [12,13]. India
ranks 140th and 136th in the world in nominal GDP  per capita and
HDI respectively [14]. India is faced with challenges of poverty, illit-
eracy, corruption, malnutrition, inadequate public healthcare and
insurgence [15]. India has largest number of people living below
the world bank’s poverty line of USS 1.25 per day [16]. Economic
inequalities between rich and poor have grown consistently since
1991 [17]. Nearly half of children under the age of 5 years are
underweight and malnourished. The prevalence of child under-
nutrition in India is among the highest in the world, nearly double
that of Sub-Saharan Africa [18]. India spends 4.1% of its GDP on
health compared to 7.6% and 5.2% of GDP expended by USA and
China respectively [19]. Indian nominal GDP per capita has grown
at rate much lower than other Asian developing countries and is
expected to remain so in the coming years [20]. Various interna-
tional ﬁnancial agencies have downgraded credit rating of India in
recent years. Although, standard and poor has upgraded credit rat-
ing after the election of new government, this upgradation is merely
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ased on assumption of implemention of policy reforms and not on
he performance of Indian economy. The doubt about comprehen-
ive recovery of Indian economy has also been cast by Governor of
eserve Bank of India as late as September 2014. With the prevail-
ng socio-economic situation, we cannot expect drastic increase in
ealth-care funding, especially the funding for radiotherapy units
21].
Each year in India, there are roughly one million new cases of
ancer and ∼50% of them require radiotherapy [22,23]. Assuming
ne machine treats 500 new cancer cases, we need a total of 2000
achines at the current incidence rate of cancer. For the year 2014,
CMR has estimated the new cancer cases at 1.2 millions and a total
f 2400 external beam radiotherapy machines are needed. India has
early 1,00,000 cervical cancer patients and brachytherapy forms
ntegral part of therapy of carcinoma cervix [24,25]. Assuming each
achine can deliver 3 fractions of high-dose-rate brachytherapy at
n interval of 1 week to 5 patients per day, 400 patients of carci-
oma cervix are treated per year per machine and we  need 250
rachytherapy machines. According to Atomic Energy Regulatory
oard, India has 469 teletherapy machines (237 Co60 + 232 medi-
al accelerators), 15 advanced therapy machines (7 Gamma  knife
nits + 1 super gamma  system + 3 tomotherapy + 2 cyber-knife + 2
ntra-operative radiotherapy) and 275 brachytherapy machines
10]. As per international standards, current Indian requirement
f radiotherapy professionals are as follows: 3300 radiation onco-
ogists at the rate of 1/300 patients, 2500 radiation physicists at
he rate of 1/400 patients, 3300 treatment planning staff at the
ate of 1/300 patients, and 6–7000 radiotherapy technologists at
he rate of 3 per machine treating up to 40 patients [26]. Apart
rom projected present requirement of radiation man-power, Task
orce Report for XI plan has also documented shortage of radiation
ncologist [27]. There are many instances of Atomic Energy Reg-
latory Board (AERB) suspending and resuspending the license of
adiotherapy departments both in the national capital and periph-
ry of India to operate even the basic radiation therapy machine
ue to shortage of adequate number of radiotherapy staff, cali-
rated dosimeters and survey meter for satisfactory performance
f Quality and assurance (QA) [28,29]. To bridge the existing gap in
nfrastructure and resources, National Cancer Control Programme
1975) has aim of establishing oncology wing in all the medical
olleges with Rs. 2 crores of ﬁnancial assistance for procurement
f cobalt therapy unit [30]. By committing itself to ﬁnance Co-60
eletherapy unit, National Cancer Control Programme has emerged
s a relevant programme in Indian context. IAEA too has regarded
o-60 as “friendlier” treatment machines to place in new low-
esource departments with regards to cost, the training required,
reatment delivery, planning, and maintenance. In contrast, linac
reatment is seven times more expensive than the therapy by Co-
0 in view of higher installation cost, limited life span of 10–12
ears, training of personnel, frequent machine break-down, costly
nd limited supply of spare parts and maintenance [31]. Cost con-
ideration is also an important factor in determination of treatment
hoice and quality of life of patients. Technological innovation is
ssociated with conﬂict of interest due to high initial cost of clini-
al application of the technology. Investigations have also revealed
exus of health-care professional trusting latest radiotherapy tech-
ology on patients solely for the purpose of ﬁnancial incentives
eave apart its rapid adoption in clinics [32]. Many experts com-
ittees have gone overboard at alienating Co60 in favour of much
ore expensive linear accelerators thereby furthering the misery
9]. Only 1% of Indian population have health insurance and just
nder 7% work in organized sectors. Therefore it is very obvious
hat India’s private expenditure on health accounts for 72 percent
f the total health expenditure. Out-of-pocket medical expenditure
s 89% of total health expenditure. As a consequence, 39 million peo-
le (3.2% of Indian population) are pushed into poverty every yearancer Policy 4 (2015) 26–30
because of health care costs [33]. In our quest to propagating newer
technologies, we should not be responsible for bankruptcy of our
patients.
Latest health insurance scheme of government of India has sig-
niﬁcantly reduced the mortality and out-of-pocket expenditure
for cancer. It covers range of radiotherapy technology from Co-
60 to IMRT. However, we  have to bear in mind that funding for
such schemes are provided by generous grants of World Bank. And
unprecedented unjustiﬁed radiotherapy technological application
may only increase India’s international debt and deﬁciencies that
have to subsequently be repaid along with interest by common
citizens of India [34].
QA programme are more complex for linac and need perennial
electricity supply unlike Co-60. Other disadvantage of advanced
radiation therapy equipments are as follows: Existing QA guide-
lines are often inadequate for these new technologies. New QA
procedures are needed and are under development. Errors in mea-
surement can be substantial and several new treatment machines
provide radiation beams that do not comply with the reference
ﬁeld dimensions given in existing dosimetry protocols thereby
complicating the accurate determination of dose for small and
non-standard beams. IMRT requires increased attention to physics
and dosimetry, more equipment, training and technical support,
and more time for quality assurance. IMRT and all other advanced
radiotherapy techniques demand increased clinician time for tar-
get and organ outlining, increased planning time (initially), and
increased machine treatment time in addition to extensive QA pro-
gramme  [31,35]. With the prevailing shortage of radiation oncology
resources, it is not practical for resource-constrained countries like
India to implement and verify the latest treatment technology. Also
of concern is unavailability of clinical data currently on long-term
outcome of advanced radiotherapy delivery system. Randomized
trials to generate outcome data of tumor control, morbidity, mor-
tality and safety of the different novel procedures are yet to be
planned for many. Adding to the former, Claims in support of pre-
vious statement is established by the fact that late toxicity proﬁle
of ablative radiotherapy has never been published till date [36].
After extensive review of radiotherapy situation across the
world, more so of low and middle income countries (LMIC), IAEA
initiative Advisory Group on Increasing Access to Radiotherapy
Technologies in developing countries (AGaRT) engage the manu-
facturers, users and experts in open forum. AGaRT is recognized as
a signiﬁcant step towards providing a viable solution (affordable,
suitable and sustainable radiotherapy equipment) to the global
shortfall of radiotherapy units. Aim of AGaRT is to encourage
development of US$ 1 million radiotherapy package of safe, high
quality, uncomplicated, easy to handle even by inexperienced, sim-
ple to control and maintain essential Co60 and linac radiotherapy
technology that does not require frequent calibration, dosimetry
measurement and onsite presence of medical physicist. Commis-
sioning of radiotherapy machine to life-time maintenance of linac
by regional experts developed under the package by the radiothe-
rapy suppliers and subsequent repatriation are all included in this
package [37].
Co-60 radiotherapy equipment is in vogue in most of the devel-
oping countries possessing at least one radiotherapy machine.
Co-60 can effectively and safely irradiate prevailing tumors in these
region by time-tested conventional techniques. However, treat-
ment technique with Co-60 or non-MLC linac is not sufﬁcient
to treat all the patients especially those with tumours of tho-
rax, abdomen, posterior neck after the tolerance limits of spinal
cord and some superﬁcial and acral tumours. Linac or Co-60 based
computer-assisted 3-D conformal radiotherapy is all that is needed
to treat these tumours. IMRT is increasingly becoming popular
now-a-days even in developing countries. Nevertheless, the dose
gradient of IMRT in many cases may  not be sufﬁcient to spare
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ormal tissue and can only be marginally better than 3-D conformal
adiotherapy. Another important limitation of IMRT is that it may
ot fulﬁll all the normal tissue dose constrain and may  sometimes
ump excess dose into other adjacent or remote critical normal
rgan. Particle therapy holds promise of signiﬁcantly avoiding crit-
cal adjacent normal tissue by the virtue of Bragg’s peak .i.e. most
f the energy of particle are release just before they come to rest.
nfortunately, particle therapy is available only in limited centres
cross the world due to its cost consideration. Linear accelerator
enerating 6 MV photon beam with additional capacity to deliver
ingle energy electron beam or Co-60 therapy machine capable of
ighly conformal treatment technique is more than sufﬁcient to
reat most of the tumours presenting in undeveloped regions of the
orld. More sophisticated technology is rarely required as 70% of
umours in developing countries are locally advanced. X-ray sim-
lator, CT simulator, mould room, computer treatment planning
ystem for 3-D CRT and brachytherapy planning are essential and
ufﬁcient for radiotherapy planning process. Remote after load-
ng high-dose rate brachytherapy is yet another requirement for
omprehensive cancer care facility.
ey messages
. Co-60 teletherapy equipment with multi-leaf collimators is all
that is needed for comprehensive radiotherapeutic management
in developing countries including India.
. Ir-192 (half-life of 73.83 days) is commonly used as radio-
active source for brachytherapy. Co-60 (half-life of 5.3 years) can
replace Ir-192 as brachytherapy source in developing countries.
c. Resident doctors should be encouraged to participate in all
aspects of handling of Co-60 tele-therapy and brachytherapy
equipments in order to increase access to radiotherapy. They
should be trained for carrying-out and reporting QA & QC of
Co-60 machines.
. Linac with specialized radiotherapy can be housed in refer-
ral, tertiary and regional cancer centres. Clinical and physical
research of new techniques and technology has to be encouraged
for safe, accurate and precise delivery of radiotherapy.
. Health-care providers in developing countries has to be made
accountable for non-functioning of radiotherapy departments.
onclusion
2/3rd of all cancer patients need life-saving radiotherapy at
ome point of their illness. Although cheapest modality of anti-
ancer therapy, huge initial out-lay for radiotherapy department
ay  make it apparently expensive and unaffordable. Unprece-
ented technological advances in radiotherapy have failed to
ncrease survival, has raised new questions on accuracy of dose
elivered and have further skewed distribution and available of
adiotherapy resources in developing countries. MLC equipped
o-60 radiotherapy machine or low-energy linac with capability
o delivery electron along with Co-60 radio-isotope based high-
ose-rate brachytherapy unit can constitute comprehensive
adiation oncology and cancer centre in developing countries.
eletherapy and brachytherapy machine with Co-60 radio-isotope
s the source of radiation may  be feasible and inexpensive option
or community-based centres in countries like India. Linac with
pecialized radiotherapy can be housed in referral, tertiary and
egional cancer centres. Linac-based and non-linac-based advanced
echniques may  be restricted for selective cases and should always
e vigorously evaluated within the scope of clinical trials over
ong-follow-up period for both tumour control and adverse events
utcomes.
[
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While attempting to reply to the discussion forum on the topic
“The fast-paced technological advancement in radiation treatment
equipment is good for Indian Scenario,” we are neither antagonist
of nor dis-contended with fast-paced technological advancement
in the ﬁeld of radiation oncology. We  believe that we should always
be part of such technological advances by continuously contribut-
ing to the progress of science and well-being of mankind. Science
has always been dynamic irrespective of ages and era and our duty,
as scholars, scientists and physicians, is to relieve the suffering of
people with the technology that is relevant, appropriate, afford-
able, socio-culturally acceptable, safe with comparable risk-beneﬁt
ratio to the standard of care technology. Medical practitioners have
to strike a ﬁne balance between delivering affordable radiothe-
rapy services to community and contributing towards the latest
advancement in their area of expertise with tilt under all circum-
stances favouring the patients to alleviate their misery. From the
above discussion, we  would like to conclude that the HDI, pat-
tern and presentation of malignant lesions, available resources and
budget outlay do not endorse the use of advanced radiotherapy
technology in Indian context.
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